OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Hepatocellular Carcinoma: Latest Research in Pathogenesis, Detection and Treatment
Beatrice Foglia, Cristian Turato, Stefania Cannito
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 15, pp. 12224-12224
Open Access | Times Cited: 27

Showing 1-25 of 27 citing articles:

Arsenic trioxide augments immunogenic cell death and induces cGAS-STING-IFN pathway activation in hepatocellular carcinoma
Xin Li, Yu‐Fei Pan, Yibin Chen, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 4
Open Access | Times Cited: 12

Biological Activity of Natural and Synthetic Peptides as Anticancer Agents
Luana Vittoria Bauso, Valeria La Fauci, S. Munaò, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 7264-7264
Open Access | Times Cited: 10

Realizing the Promise of Artificial Intelligence in Hepatocellular Carcinoma through Opportunities and Recommendations for Responsible Translation
Tamer A. Addissouky, Majeed M. A. Ali, Ibrahim El Tantawy El Sayed, et al.
Jurnal Online Informatika (2024) Vol. 9, Iss. 1, pp. 70-79
Open Access | Times Cited: 5

Alkaloid-Based Modulators of the PI3K/Akt/mTOR Pathway for Cancer Therapy: Understandings from Pharmacological Point of View
Fatima Zohra Mokhfi, Md. Al Amin, Mehrukh Zehravi, et al.
Chemico-Biological Interactions (2024) Vol. 402, pp. 111218-111218
Closed Access | Times Cited: 4

Circulating tumor DNA methylation markers for the early diagnosis of hepatocellular carcinoma
Chang-Yi Lu, Kun‐Feng Tsai, Chia‐Jui Yen, et al.
Clinical and Experimental Medicine (2025) Vol. 25, Iss. 1
Open Access

Clonorchis sinensis-infected hepatocellular carcinoma exhibits distinct tumor microenvironment and molecular features
Junxian Chen, Caibiao Wei, Wen‐Cheng Huang, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access

A Chemotherapy Response-Related Gene Signature and DNAJC8 as Key Mediators of Hepatocellular Carcinoma Progression and Drug Resistance
Yan Ye, Yanmei Zeng, Shan Huang, et al.
Journal of Hepatocellular Carcinoma (2025) Vol. Volume 12, pp. 579-595
Open Access

Hepatocellular carcinoma: what are the differential costs compared to the general population?
Josep Darbà, Meritxell Ascanio
Journal of Medical Economics (2025), pp. 1-15
Open Access

Therapeutic potential of Bacopa monnieri extracts against hepatocellular carcinoma through in-vitro and computational studies
Awais Altaf, Asia Kiran, Muhammad Sarwar, et al.
PLoS ONE (2025) Vol. 20, Iss. 4, pp. e0321445-e0321445
Open Access

The Biological Clock of Liver Metabolism in Metabolic Dysfunction-Associated Steatohepatitis Progression to Hepatocellular Carcinoma
Pradeep Rajan, Utibe-Abasi Udoh, Robert J. Finley, et al.
Biomedicines (2024) Vol. 12, Iss. 9, pp. 1961-1961
Open Access | Times Cited: 3

Combining Liver-Directed and Immunotherapy in Advanced Hepatocellular Carcinoma: A Review and Future Directions
Pranav Kumar, Chase J. Wehrle, Keyue Sun, et al.
Surgical Oncology Insight (2024), pp. 100100-100100
Open Access | Times Cited: 3

Modulation of Tumor-Associated Macrophages to Overcome Immune Suppression in the Hepatocellular Carcinoma Microenvironment
Mahmoud Singer, Zhuoli Zhang, Farshid Dayyani, et al.
Cancers (2024) Vol. 17, Iss. 1, pp. 66-66
Open Access | Times Cited: 3

LncRNA CRNDE promotes hepatoma cell proliferation by regulating the metabolic reprogramming of M2 macrophages via ERK pathway
Lin Chao, Tao Jiang, E Changyong, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 2

Pathological roles of lncRNA HOTAIR in liver cancer: An updated review
Chou‐Yi Hsu, Azfar Jamal, Mohammad Azhar Kamal, et al.
Gene (2024) Vol. 940, pp. 149180-149180
Closed Access | Times Cited: 2

Development of samarium-doped phosphate glass microspheres for internal radiotheranostic applications
Andi Arjuna, Ben Milborne, Amal Rezka Putra, et al.
International Journal of Pharmaceutics (2024) Vol. 653, pp. 123919-123919
Closed Access | Times Cited: 1

Dual Roles of microRNA-122 in Hepatocellular Carcinoma and Breast Cancer Progression and Metastasis: A Comprehensive Review
Essam Al Ageeli
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 11, pp. 11975-11992
Open Access | Times Cited: 1

Rational design, synthesis, biological evaluation, molecular docking, and molecular dynamics of substituted uracil derivatives as potent anti-cancer agents
Ebtessam A Basiony, Allam A. Hassan, Mohamed Elsawalhy, et al.
Bioorganic Chemistry (2024) Vol. 154, pp. 108066-108066
Closed Access | Times Cited: 1

New challenges in hepatocellular carcinoma: A role for PIWI-interacting RNAs?
Domenico Tierno, Gabriele Grassi, Bruna Scaggiante
World Journal of Gastroenterology (2024) Vol. 30, Iss. 22, pp. 2843-2848
Open Access

Uncovering the regulatory roles of miR-4319 in tumour progression
Zhi Xiong Chong
Human Gene (2024) Vol. 41, pp. 201312-201312
Closed Access

RNA Interference based Midkine Gene Therapy for Hepatocellular Carcinoma
Samah Mamdouh, Fatma Khorshed, Gehan Hammad, et al.
Asian Pacific Journal of Cancer Prevention (2024) Vol. 25, Iss. 7, pp. 2371-2379
Open Access

Acetazolamide suppresses the progression of hepatocellular carcinoma induced by diethylnitrosamine in Wistar albino rats
Yomna M. Tamim, Mohamed Soliman, Moataz M. Sayed, et al.
Fundamental and Clinical Pharmacology (2024) Vol. 38, Iss. 6, pp. 1045-1058
Open Access

Page 1 - Next Page

Scroll to top